AZTA
Price
$52.63
Change
-$0.37 (-0.70%)
Updated
Jan 17 closing price
Capitalization
3.36B
24 days until earnings call
NVRO
Price
$4.57
Change
+$0.07 (+1.56%)
Updated
Jan 17 closing price
Capitalization
525.59M
32 days until earnings call
Ad is loading...

AZTA vs NVRO

Header iconAZTA vs NVRO Comparison
Open Charts AZTA vs NVROBanner chart's image
Azenta
Price$52.63
Change-$0.37 (-0.70%)
Volume$372.1K
Capitalization3.36B
NEVRO
Price$4.57
Change+$0.07 (+1.56%)
Volume$388.86K
Capitalization525.59M
AZTA vs NVRO Comparison Chart
Loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTA vs. NVRO commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Hold and NVRO is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (AZTA: $52.63 vs. NVRO: $4.57)
Brand notoriety: AZTA and NVRO are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 42% vs. NVRO: 68%
Market capitalization -- AZTA: $3.36B vs. NVRO: $525.59M
AZTA [@Medical Specialties] is valued at $3.36B. NVRO’s [@Medical Specialties] market capitalization is $525.59M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileNVRO’s FA Score has 0 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • NVRO’s FA Score: 0 green, 5 red.
According to our system of comparison, AZTA is a better buy in the long-term than NVRO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 2 TA indicator(s) are bullish while NVRO’s TA Score has 3 bullish TA indicator(s).

  • AZTA’s TA Score: 2 bullish, 3 bearish.
  • NVRO’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, both AZTA and NVRO are a bad buy in the short-term.

Price Growth

AZTA (@Medical Specialties) experienced а +1.80% price change this week, while NVRO (@Medical Specialties) price change was +38.91% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

AZTA is expected to report earnings on May 12, 2025.

NVRO is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AZTA($3.36B) has a higher market cap than NVRO($526M). NVRO YTD gains are higher at: 22.849 vs. AZTA (5.260). AZTA has higher annual earnings (EBITDA): 57.5M vs. NVRO (-78.31M). AZTA has more cash in the bank: 984M vs. NVRO (323M). AZTA has less debt than NVRO: AZTA (66.5M) vs NVRO (216M). AZTA has higher revenues than NVRO: AZTA (641M) vs NVRO (425M).
AZTANVROAZTA / NVRO
Capitalization3.36B526M639%
EBITDA57.5M-78.31M-73%
Gain YTD5.26022.84923%
P/E RatioN/A147.06-
Revenue641M425M151%
Total Cash984M323M305%
Total Debt66.5M216M31%
FUNDAMENTALS RATINGS
AZTA vs NVRO: Fundamental Ratings
AZTA
NVRO
OUTLOOK RATING
1..100
2013
VALUATION
overvalued / fair valued / undervalued
1..100
71
Overvalued
84
Overvalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
9295
PRICE GROWTH RATING
1..100
4464
P/E GROWTH RATING
1..100
6198
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (71) in the Electronic Production Equipment industry is in the same range as NVRO (84) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to NVRO’s over the last 12 months.

AZTA's Profit vs Risk Rating (83) in the Electronic Production Equipment industry is in the same range as NVRO (100) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to NVRO’s over the last 12 months.

AZTA's SMR Rating (92) in the Electronic Production Equipment industry is in the same range as NVRO (95) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to NVRO’s over the last 12 months.

AZTA's Price Growth Rating (44) in the Electronic Production Equipment industry is in the same range as NVRO (64) in the Medical Specialties industry. This means that AZTA’s stock grew similarly to NVRO’s over the last 12 months.

AZTA's P/E Growth Rating (61) in the Electronic Production Equipment industry is somewhat better than the same rating for NVRO (98) in the Medical Specialties industry. This means that AZTA’s stock grew somewhat faster than NVRO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTANVRO
RSI
ODDS (%)
Bearish Trend 11 days ago
83%
Bullish Trend 11 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 11 days ago
73%
Bullish Trend 11 days ago
78%
Momentum
ODDS (%)
N/A
Bearish Trend 11 days ago
84%
MACD
ODDS (%)
N/A
Bearish Trend 11 days ago
79%
TrendWeek
ODDS (%)
Bullish Trend 11 days ago
72%
Bearish Trend 11 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 11 days ago
76%
Bearish Trend 11 days ago
86%
Advances
ODDS (%)
Bullish Trend 12 days ago
72%
Bullish Trend 24 days ago
71%
Declines
ODDS (%)
Bearish Trend 20 days ago
84%
Bearish Trend 11 days ago
85%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 11 days ago
83%
Bearish Trend 11 days ago
90%
View a ticker or compare two or three
Ad is loading...
AZTA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NVRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GPIGX13.320.10
+0.76%
Guidepath® Growth and Income
NPFCX59.080.38
+0.65%
American Funds New Perspective C
FLKSX14.950.07
+0.47%
Fidelity Low-Priced Stock K6
MLVMX18.770.04
+0.21%
MFS Low Volatility Equity R1
LYRIX27.040.05
+0.19%
Lyrical US Value Equity Institutional

AZTA and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTA has been loosely correlated with CRL. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if AZTA jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTA
1D Price
Change %
AZTA100%
-0.70%
CRL - AZTA
54%
Loosely correlated
-1.39%
BLFS - AZTA
48%
Loosely correlated
-1.17%
IQV - AZTA
47%
Loosely correlated
-0.15%
A - AZTA
44%
Loosely correlated
+1.82%
RVTY - AZTA
44%
Loosely correlated
-0.90%
More